v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities      
Net loss $ (13,288,000) $ (8,538,000) $ (4,556,000)
Adjustment to reconcile net loss to cash used in operating activities:      
Amortization of intangible assets 7,000 18,000 7,000
Depreciation of property and equipment 131,000 81,000 23,000
Allowance for (reversal of) credit losses 453,000 (502,000) 854,000
Loss on disposal of intangible assets 12,000
Share-based compensations 3,221,000 3,312,000 3,810,000
Share of results of an associate (30,000) 54,000 3,000
Loss on disposal of an associate 100,000
Impairment loss of long-term investments 290,000
Interest income from loan receivable (26,000) (26,000)
Loss on fair value change of convertible notes 232,000
Change in operating assets and liabilities:      
Change in receivables from customers (11,762,000) 2,770,000 (2,038,000)
Change in receivables from brokers-dealers and clearing organizations (716,000) 660,000 (376,000)
Change in refundable deposits (89,000) (399,000) (462,000)
Change in prepaid expenses and other current assets (1,842,000) 999,000 (1,656,000)
Change in amount due from a director 28,000
Change in amounts with related parties 2,188,000
Change in payables to AI cloud service providers 10,449,000
Change in payables to customers (2,185,000) (89,000) (1,235,000)
Change in contract liabilities (120,000)
Change in accruals and other current liabilities 1,872,000 292,000 69,000
Change in right to receive cryptocurrencies (4,014,000)
Change in income taxes payable (55,000) 55,000
Change in operating lease liabilities 26,000 (24,000) 13,000
Cash used in operating activities (15,335,000) (1,057,000) (5,607,000)
Cash flows from investing activities      
Purchase of intangible assets (540,000) (27,000) (20,000)
Purchase of property and equipment (186,000) (88,000) (141,000)
Purchase of long-term investments, net (126,000) (658,000)
Acquisition of an associate (257,000)
Proceeds from disposal of an associate 50,000
Acquisition of subsidiaries under common control 5,304,000
Repayment of loan to a third party 1,010,000
Loan to a third party (958,000)
Cash provided by (used in) investing activities 4,452,000 287,000 (1,376,000)
Cash flows from financing activities      
Proceeds from shareholders’ contribution 1,000,000
Proceeds from capital injection from investors 16,878,000
Net proceeds from initial public offering (“IPO”) 7,065,000
Proceeds from other borrowings 420,000
Payment for IPO costs (409,000)
Advance to related parties 14,000 61,000
Proceeds from issuance of convertible notes 5,000,000
Advance from directors 942,000 3,000
Repayments to directors (804,000)
Cash provided by financing activities 21,074,000 2,376,000 6,720,000
Net change in cash, cash equivalents and cash segregated for regulatory purpose 10,191,000 1,606,000 (263,000)
Cash, cash equivalents and cash segregated for regulatory purpose at beginning of the year 8,857,000 7,251,000 7,514,000
Cash, cash equivalents and cash segregated for regulatory purpose at the end of the year 19,048,000 8,857,000 7,251,000
Supplementary cash flows information      
Cash received from interest 7,000 46,000 29,000
Cash paid for income taxes 74,000 101,000
Supplemental schedule of non-cash investing and financing activities      
Repayment of loans through issuance of shares 424,000
Acquisition of an associate through issuance of Class A Ordinary Shares 7,500,000
Operating lease right-of-use assets obtained in exchange for operating lease liabilities 1,034,000 273,000 1,044,000
Reconciliation to amounts on consolidated balance sheets:      
Cash and cash equivalents 16,804,000 3,838,000 2,140,000
Cash segregated for regulatory purpose 2,244,000 5,019,000 5,111,000
Total cash, cash equivalents and cash segregated for regulatory purpose $ 19,048,000 $ 8,857,000 $ 7,251,000